EMA
guidance
· 2013-11-22
European Medicines Agency advises on compassionate use of daclatasvir
Summary
The European Medicines Agency provides guidance on compassionate use of the antiviral daclatasvir, outlining conditions and considerations for access outside of…
Upgrade for the full analysis, importance score, and drug timeline.